PCSK9 siRNA, on top of maximally tolerated statin therapy, potently lowers LDL-c - PACE-CME

PCSK siRNA on top of maximally tolerated statin therapy potently lowers LDLc

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

GLP-1RA treatment effect in patients with T2DM and PAD
GLP-1RA treatment effect in patients with T2DM and PAD
AHA 2019
GLP-1RA treatment effect in patients with T2DM and PAD
- Subodh Verma, MD, PhD
Possible favorable effects of icosapent ethyl on plaque-parameters
Possible favorable effects of icosapent ethyl on plaque-parameters
AHA 2019
Possible favorable effects of icosapent ethyl on plaque-parameters
- Prof. Stephen Nicholls
Fish oil treatment reduces several plaque parameters after 9 months
Fish oil treatment reduces several plaque parameters after 9 months
AHA 2019
Fish oil treatment reduces several plaque parameters after 9 months
- Prof. Lawrence Leiter, MD
Patients with moderate ischemia on a stress test do not need to go straight to the cathlab
Patients with moderate ischemia on a stress test do not need to go straight to the cathlab
AHA 2019
Patients with moderate ischemia on a stress test do not need to go straight to the cathlab
- Prof. Donald Lloyd-Jones